Form 8-K Horizon Therapeutics For: Nov 29

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. SPY
6. NVDA
7. WMT
8. RXST
9. RIVN
10. LMT

Go back to Form 8-K Horizon Therapeutics For: Nov 29

Jefferies sees up to 90% chance Horizon Therapeutics (HZNP) gets acquired, with $125 base case

December 1, 2022 11:06 AM EST

Jefferies analyst Akash Tewari was the latest Wall Street analyst to weigh in on the takeover prospects of Horizon Therapeutics (NASDAQ: HZNP) after the company announced Tuesday that it is in preliminary talks with three large pharmaceutical companies about a potential buyout.

Tewari is positive on the prospects of a deal and sees one happening in the $25-$30 billion range, which he also said does not bake in Tepezza peak sales of $4 billion.

The analyst said the... More

Horizon Therapeutics seen worth up to $140/share in takeover

November 30, 2022 8:12 AM EST

Several Wall Street analysts put pencil to paper after Horizon Therapeutics (NASDAQ: HZNP) said Tuesday evening that it was in "highly preliminary" takeover talks with Amgen Inc. (NYSE: AMGN), Janssen Global Services, LLC (NYSE: JNJ), and Sanofi (NYSE: SNY). A deal price as high as $140 per share was the high watermark discussed by at least two analysts.

Cowen analyst Ken Cacciatore said that given their belief that Tepezza's previous pause was... More